Skip to main content
. 2017 Sep 20;14(134):20170320. doi: 10.1098/rsif.2017.0320

Figure 4.

Figure 4.

Individual variation of pretreatment patterns among simulated tumours in patients with different tumour neoantigen characteristics at day 30. A tumour slice from a patient with (a) tumour neoantigens of low mutational burden and high antigen strength; (b) high mutational burden and high antigen strength; (c) low mutational burden and low antigen strength; (d) high mutational burden and low antigen strength.